Advertisements



Reckitt to pay $1.4 billion to end U.S. opioid addiction treatment probes

Reckitt Benckiser has agreed to pay up to $1.4 billion to resolve U.S. claims that its former pharmaceuticals business Indivior before it was spun out of the company carried out an illegal scheme to boost sales of an opioid addiction treatment......»»

Category: topSource: reutersJul 11th, 2019

Reckitt to pay $1.4 billion to end opioid addiction treatment probes

Reckitt Benckiser has agreed to pay up to $1.4 billion to end U.S. federal investigations into the marketing of an opioid addiction treatment by its former business Indivior, lifting a cloud that has been hanging over the British company for years......»»

Category: topSource: reutersJul 11th, 2019

Reckitt to pay $1.4 billion to end long-running Indivior probes

Britain's Reckitt Benckiser has agreed to pay up to $1.4 billion to resolve all U.S. federal investigations into the sales and marketing of an opioid addiction treatment by its former prescription pharmaceuticals business Indivior ......»»

Category: topSource: reutersJul 11th, 2019

Chautauqua hospital funded for 100-slot addictions program

A Jamestown hospital will expand its addiction program with an additional 100 slots for outpatient treatment. UPMC Chautauqua received new funding from the state Office of Addiction Services and Supports to establish a new opioid treatment program .....»»

Category: topSource: bizjournals18 hr. 36 min. ago

Opioid settlements could provide more than $23 billion in medicine to treat addiction — but health-care providers say that won’t go far enough

Millions people caught up in the opioid epidemic have difficulty paying for treatments and accessing health care......»»

Category: topSource: marketwatchOct 23rd, 2019

Dispensed: Ancestry"s big move into healthcare, digital health"s disruption of addiction treatment, and investors" multi-billion-dollar bet on the microbiome

Hello, Welcome to another edition of Dispensed, the weekly healthcare newsletter where we're busy compiling names for our DC power-players post (if you haven'.....»»

Category: topSource: businessinsiderOct 18th, 2019

Largest opioid settlement: Suboxone maker to pay $1.4B

Suboxone maker Reckitt Benckiser Group will pay the U.S. government a record $1.4 billion to settle claims about its role in the country's opioid crisis......»»

Category: topSource: moneycentralJul 12th, 2019

Largest opioid settlement in US history: Suboxone maker to pay $1.4B

Suboxone maker Reckitt Benckiser Group will pay the U.S. government a record $1.4 billion to settle claims about its role in the country's opioid crisis......»»

Category: topSource: moneycentralJul 12th, 2019

Inside Elizabeth Warren’s $100 Billion Policy Plan to Tackle the Opioid Epidemic

The proposal treats addiction as a public health issue. Massachusetts Sen. Elizabeth Warren has consistently rolled out a number of progressive policy platforms in recent .....»»

Category: europeSource: fortuneMay 9th, 2019

Inside Elizabeth Warren’s $100 Billion Plan to Tackle the Opioid Epidemic

The proposal treats addiction as a public health issue. Massachusetts Sen. Elizabeth Warren has consistently rolled out.....»»

Category: europeSource: fortuneMay 8th, 2019

Prosecutors Say Drugmaker Indivior Lied About Popular Opioid Treatment

Indivior Plc slumped to its lowest level ever after U.S. prosecutors charged the U.K. company with allegedly deceiving health-care providers about its opioid-addiction treatment while downplaying the risk of misuse......»»

Category: topSource: moneycentralApr 10th, 2019

Indivior shares tank after U.S. indictment for illegal marketing

Shares of Indivior Plc sank 44 percent on Wednesday after the U.S. Justice Department accused the British drugmaker of illegally boosting prescriptions for the film version of its blockbuster opioid addiction treatment Suboxone......»»

Category: topSource: reutersApr 10th, 2019

The Wall Street Journal: U.S. prosecutors accuse U.K.-based Indivior with fraud over opioid-addiction treatment

As part of an indictment f.....»»

Category: topSource: marketwatchApr 10th, 2019

CareFirst issues RFP as part of program to fight opioid abuse

CareFirst BlueCross BlueShield has put out a call for organizations to help with a program to increase substance use disorder services and opioid addiction treatment. As part of recently issued request for proposals, Baltimore-based CareFirst plans to.....»»

Category: topSource: bizjournalsApr 9th, 2018

FDA Approves Nonopioid Treatment for Opioid Withdrawal Symptoms

The U.S. Food and Drug Administration has approved the first nonopioid treatment to help adults manage opioid withdrawal symptoms as the agency looks to continue to encourage the development of therapies to help patients suffering from addiction......»»

Category: smallbizSource: wsjMay 16th, 2018

House passes Mass. congresswoman"s bill to ease addiction workforce shortage

A bipartisan effort to encourage more people to enter jobs in the substance abuse treatment field cleared the U.S. House this week, as lawmakers considered a series of bills aimed at addressing issues related to the opioid epidemic. U.S. Rep. Katherin.....»»

Category: topSource: bizjournalsJun 14th, 2018

Dr. Reddy"s/Mylan Get FDA Nod for First Generic of Suboxone

Dr. Reddy's (RDY) and Mylan announced that the FDA approved the first generic version of Suboxone (Buprenorphine and Naloxone Sublingual Film) under-the-tongue film for the treatment of opioid addiction. Dr. Reddy’s Laboratories Ltd. RDY.....»»

Category: smallbizSource: nytJun 15th, 2018

A member of the rich family behind OxyContin was granted a patent for addiction treatment

AP Photo/Toby Talbot, File Dr. Richard Sackler, a member of the family that owns Purdue Pharma, was one of the six inventors awarded a patent for a treatment for opioid-use disorder. Critics told the Financial Times th.....»»

Category: topSource: businessinsiderSep 7th, 2018

OxyContin billionaire granted patent for addiction treatment

A billionaire pharmaceuticals executive who has been blamed for spurring the US opioid crisis stands to profit from the epidemic after he patented a new treatment for drug addicts......»»

Category: topSource: moneycentralSep 7th, 2018

OxyContin billionaire granted patent for addiction treatment

A billionaire pharmaceuticals executive who has been blamed for spurring the US opioid crisis stands to profit from the epidemic after he patented a new treatment for drug addicts......»»

Category: topSource: moneycentralSep 7th, 2018

OxyContin Billionaire Granted Patent for Opioid Addiction Treatment

Richard Sackler was given a patent for a novel form of buprenorphine, a mild opiate that controls drug cravings. Purdue Pharma has long been criticized for aggressively marketin.....»»

Category: europeSource: fortuneSep 7th, 2018